Grifols | GRFS - Beneficio Bruto En Ventas

Precio De Mercado
8.21
Cambio Diario
0.16 1.99%
Mensual
2.24%
Anual
21.45%
Q2 Expectativa
7.99




Beneficio Bruto En Ventas Cambio Fecha
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Arca Biopharma 0 0 2025-03
aTyr Pharma USD 190K 15.57M 2025-09
Capricor Therapeutics 11.13M 8.87M 2024-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Esperion Therapeutics USD 140.59M 94.57M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Grifols EUR 766.49M 39.74M 2024-12
Immunic 0 0 2025-03
Infinity Pharmaceuticals USD 231K 59K 2023-06
Minerva Neurosciences -4.27M 26.79M 2024-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
TherapeuticsMD USD 234K 79K 2024-06